Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.42B |
| 2 |
Vale
VALE
|
+$1.05B |
| 3 |
Freeport-McMoran
FCX
|
+$988M |
| 4 |
Micron Technology
MU
|
+$690M |
| 5 |
ExxonMobil
XOM
|
+$534M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.21B |
| 2 |
TC Energy
TRP
|
+$1.37B |
| 3 |
Microsoft
MSFT
|
+$1.32B |
| 4 |
Verizon
VZ
|
+$1.31B |
| 5 |
Amazon
AMZN
|
+$940M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 16.54% |
| 3 | Communication Services | 12.92% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Truist Financial
TFC
$64.3B
| $63.5M | 0.02% |
1,365,105
-340,970
| -20% | -$16.6M |
|
302
MakeMyTrip
MMYT
$5.67B
| $62.9M | 0.02% |
2,278,844
-8,146
| -0.4% | -$222K |
|
303
State Street
STT
$52.2B
| $62.6M | 0.02% |
951,046
+16
| +0% | +$1.11K |
|
304
Evolent Health
EVH
$471M
| $62.4M | 0.02% |
4,957,412
-2,684,725
| -35% | -$42.5M |
|
305
Viavi Solutions
VIAV
$10.6B
| $61.6M | 0.02% |
4,972,256
-7,150,989
| -59% | -$83.8M |
|
306
Wyndham Hotels & Resorts
WH
$5.49B
| $61.1M | 0.02% |
+1,223,000
| New | +$61.8M |
|
307
Visa
V
$671B
| $60.2M | 0.02% |
385,300
-1,800,048
| -82% | -$259M |
|
308
Encompass Health
EHC
$12.3B
| $59.6M | 0.02% |
1,282,643
| – | – |
|
|
TIF
309
DELISTED
Tiffany & Co.
TIF
| $59.3M | 0.02% |
561,900
| – | – |
|
310
Elastic
ESTC
$8.02B
| $57.8M | 0.02% |
723,410
+673,410
| +1,347% | +$56.2M |
|
311
ManpowerGroup
MAN
$2.61B
| $57.3M | 0.02% |
693,000
| – | – |
|
|
CCI.PRA
312
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $56.6M | 0.02% |
47,800
| – | – |
|
313
Kimco Realty
KIM
$16.2B
| $54.5M | 0.02% |
2,944,000
+100,000
| +4% | +$1.72M |
|
|
NCNA
314
NuCana
NCNA
$5.95M
| $53.9M | 0.02% |
634
| – | – |
|
|
CVSA
315
Covista Inc
CVSA
$4.36B
| $53.6M | 0.02% |
1,157,000
| – | – |
|
316
Cognex
CGNX
$10.2B
| $53.4M | 0.02% |
1,050,000
| – | – |
|
|
INXN
317
DELISTED
Interxion Holding N.V.
INXN
| $53.4M | 0.02% |
800,000
| – | – |
|
318
Mercury Insurance
MCY
$5.84B
| $52.6M | 0.02% |
1,050,000
-51,736
| -5% | -$2.69M |
|
319
M&T Bank
MTB
$36.6B
| $52.4M | 0.02% |
333,600
| – | – |
|
320
Ferrari
RACE
$71.6B
| $52.3M | 0.02% |
390,000
| – | – |
|
321
McCormick & Company Non-Voting
MKC
$14.2B
| $52.1M | 0.02% |
+692,262
| New | +$46.7M |
|
322
BP
BP
$111B
| $51.4M | 0.02% |
+1,195,831
| New | +$49M |
|
|
KREF
323
KKR Real Estate Finance Trust
KREF
$493M
| $50.9M | 0.02% |
2,542,300
| – | – |
|
|
GOOS
324
Canada Goose Holdings
GOOS
$844M
| $50.6M | 0.02% |
1,054,500
+264,500
| +33% | +$13.5M |
|
|
COUP
325
DELISTED
Coupa Software Incorporated
COUP
| $48.6M | 0.02% |
534,000
| – | – |
|
Similar funds
Capital Research Global Investors's Q1 2019 Portfolio in Review
As of Q1 2019, Capital Research Global Investors held 442 positions worth $315B, up 9.9% from $287B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q1 2019 filing shows 25 new, 151 increased, 166 reduced and 27 closed positions. Its largest new stake was Micron Technology: 17,867,672 shares worth $738M. The largest sale was AbbVie, an estimated $2.21B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q1 2019 buy was Micron Technology: 17,867,672 shares worth $738M.
- Capital Research Global Investors added most to Alibaba in Q1 2019, an estimated $1.42B increase.
- Capital Research Global Investors's biggest Q1 2019 reduction was AbbVie, cutting an estimated $2.21B.
- Capital Research Global Investors fully exited TC Energy in Q1 2019, selling an estimated $1.37B.
- Capital Research Global Investors's ten largest holdings make up 27% of its $315B portfolio in Q1 2019.
- Capital Research Global Investors opened 25 new positions and closed 27 in Q1 2019.
- Capital Research Global Investors's portfolio value rose 9.9% quarter-over-quarter to $315B.
Based on Capital Research Global Investors's 13F filing for Q1 2019, filed 15 May 2019.